{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreif3r45r4j5nrjgj7kfw3jmvqoddw7wfa7ts3chh5svgj5b2rpxd7y",
    "uri": "at://did:plc:p3227y2hdjlcc64d55t4c5y4/app.bsky.feed.post/3mk2mvkxzh6w2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreibjpldqqcbvwdpqro6bqxsg76th5wzi3zh3457hquzkrt6wqlrehi"
    },
    "mimeType": "image/jpeg",
    "size": 86744
  },
  "path": "/2026/04/22/trumps-embrace-of-psychedelic-therapy-leaves-most-users-on-the-wrong-side-of-the-law/",
  "publishedAt": "2026-04-22T04:01:18.000Z",
  "site": "https://reason.com",
  "tags": [
    "Addiction",
    "Drug Policy",
    "MDMA",
    "Medicine",
    "Psychedelics",
    "War on Drugs",
    "Donald Trump",
    "FDA",
    "Psilocybin",
    "Psychology/Psychiatry",
    "PTSD",
    "Regulation",
    "Research",
    "Trump Administration",
    "Veterans"
  ],
  "textContent": "psilocybin mushrooms against a backdrop of the U.S. Constitution",
  "title": "Trump's Embrace of Psychedelic Therapy Leaves Most Users on the Wrong Side of the Law"
}